Abstract
The emergence and transmission of antibiotic resistance is a global public health crisis with significant burden on healthcare systems, resulting in high mortality and economic costs. In 2019, almost five million deaths were associated with drug-resistant infections, and if left unchecked, the global economy could lose $100 trillion by 2050. To effectively combat this crisis, it is essential for all countries to understand the current situation of antibiotic resistance. In this review, we examine the current driving factors leading to the crisis, impact of critical superbugs in three regions, and identify novel mechanisms of antibiotic resistance. It is crucial to monitor the phenotypic characteristics of drug-resistant pathogens and describe the mechanisms involved in preventing the emergence of cross-resistance to novel antimicrobials. Additionally, maintaining an active pipeline of new antibiotics is essential for fighting against diverse antibiotic-resistant pathogens. Developing antibacterial agents with novel mechanisms of action is a promising way to combat increasing antibiotic-resistant pathogens.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
Not applicable.
References
Al-Tawfiq JA, Momattin H, Al-Ali AY et al (2022) Antibiotics in the pipeline: a literature review (2017–2020). Infection 50:553–564. https://doi.org/10.1007/s15010-021-01709-3
Andrei S, Droc G, Stefan G (2019) FDA approved antibacterial drugs: 2018–2019. Discoveries 7:e102. https://doi.org/10.15190/d.2019.15
Asokan G, Ramadhan T, Ahmed E, Sanad H (2019) WHO global priority pathogens list: a bibliometric analysis of Medline-Pubmed for knowledge mobilization to infection prevention and control practices in Bahrain. Oman Med J 34:184–193. https://doi.org/10.5001/omj.2019.37
Ayikpoe RS, Shi C, Battiste AJ et al (2022) A scalable platform to discover antimicrobials of ribosomal origin. Nat Commun 13:6135. https://doi.org/10.1038/s41467-022-33890-w
Biswas S (2023) Synthesis of a novel lantibiotic using mutacin II biosynthesis apparatus. Microbiol Spectr. https://doi.org/10.1128/spectrum.03030-22
Butler MS, Gigante V, Sati H et al (2022) Analysis of the clinical pipeline of treatments for drug-resistant bacterial infections: despite progress, more action is needed. Antimicrob Agents Chemother. https://doi.org/10.1128/aac.01991-21
Cavaco M, Castanho MARB, Neves V (2022) The use of antibody-antibiotic conjugates to fight bacterial infections. Front Microbiol. https://doi.org/10.3389/fmicb.2022.835677
CDC (2021) Carbapenem-resistant Acinetobacter baumannii (CRAB): an urgent public health threat in United States healthcare facilities. https://arpsp.cdc.gov/story/cra-urgent-public-health-threat. Accessed 21 Sep 2023
Centers for Disease Control and Prevention (2019) 2019 AR threats report. https://www.cdc.gov/drugresistance/biggest-threats.html. Accessed 14 Sep 2023
Centers for Disease Control and Prevention (2020) About antibiotic resistance. https://www.cdc.gov/drugresistance/about.html. Accessed 25 Nov 2021
Centers for Disease Control and Prevention (2022) Carbapenem-resistant Enterobacterales (CRE) and Pseudomonas aeruginosa (CRPA) carrying multiple targeted carbapenemase genes. https://arpsp.cdc.gov/profile/multi-mechanism/2021. Accessed 21 Sep 2023
Chen S, Liu D, Zhang Q, Guo P, Ding S, Shen J, Zhu K, Lin W (2021) A marine antibiotic kills multidrug-resistant bacteria without detectable high-level resistance. ACS Infect Dis 7:884–893. https://doi.org/10.1021/acsinfecdis.0c00913
Dai C, Zhou M, Jiang W et al (2020) Breaking or following the membrane-targeting mechanism: exploring the antibacterial mechanism of host defense peptide mimicking poly(2-oxazoline)s. J Mater Sci Technol 59:220–226. https://doi.org/10.1016/j.jmst.2020.06.006
de Kraker MEA, Stewardson AJ, Harbarth S (2016) Will 10 million people die a year due to antimicrobial resistance by 2050? PLoS Med 13:e1002184. https://doi.org/10.1371/journal.pmed.1002184
FDA (2019) FDA approves new antibacterial drug to treat complicated urinary tract infections as part of ongoing efforts to address antimicrobial resistance. https://www.fda.gov/news-events/press-announcements/fda-approves-new-antibacterial-drug-treat-complicated-urinary-tract-infections-part-ongoing-efforts. Accessed 24 Sep 2023
Forde BM, Henderson A, Playford EG et al (2021) Fatal respiratory diphtheria caused by β-lactam–resistant Corynebacterium diphtheriae. Clin Infect Dis 73:e4531–e4538. https://doi.org/10.1093/cid/ciaa1147
Fraile-Ribot PA, Cabot G, Mulet X et al (2018) Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa. J Antimicrob Chemother 73:658–663. https://doi.org/10.1093/jac/dkx424
Gaibani P, Giani T, Bovo F et al (2022) Resistance to ceftazidime/avibactam, meropenem/vaborbactam and imipenem/relebactam in gram-negative MDR bacilli: molecular mechanisms and susceptibility testing. Antibiotics 11:628. https://doi.org/10.3390/antibiotics11050628
Gil-Gil T, Corona F, Martínez JL, Bernardini A (2020) The inactivation of enzymes belonging to the central carbon metabolism is a novel mechanism of developing antibiotic resistance. mSystems. https://doi.org/10.1128/mSystems.00282-20
Golikova MV, Strukova EN, Portnoy YA, Dovzhenko SA, Kobrin MB, Zinner SH, Firsov AA (2019) A novel parameter to predict the effects of antibiotic combinations on the development of Staphylococcus aureus resistance: in vitro model studies at subtherapeutic daptomycin and rifampicin exposures. J Chemother 31:320–328. https://doi.org/10.1080/1120009X.2019.1640924
Goryluk-Salmonowicz A, Popowska M (2022) Factors promoting and limiting antimicrobial resistance in the environment—existing knowledge gaps. Front Microbiol. https://doi.org/10.3389/fmicb.2022.992268
Guo Y, Gao J, Wang Z, Cui Y, Li Z, Wu Z, Zhao Y, Li D, Dai H (2022) The fate and behavior mechanism of antibiotic resistance genes and microbial communities in flocs, aerobic granular and biofilm sludge under chloroxylenol pressure. J Hazard Mater 438:129465. https://doi.org/10.1016/j.jhazmat.2022.129465
Hashemi P, Mahmoodi S, Ghasemian A (2023) An updated review on oral protein-based antigen vaccines efficiency and delivery approaches: a special attention to infectious diseases. Arch Microbiol 205:289. https://doi.org/10.1007/s00203-023-03629-2
Huang D, Pachuda N, Sauer JM, Dobbins D, Steckbeck J (2021) The engineered antibiotic peptide PLG0206 eliminates biofilms and is a potential treatment for periprosthetic joint infections. Antibiotics 11:41. https://doi.org/10.3390/antibiotics11010041
Huemer M, Shambat SM, Brugger SD, Zinkernagel AS (2020) Antibiotic resistance and persistence—implications for human health and treatment perspectives. EMBO Rep. https://doi.org/10.15252/embr.202051034
Hwang AY, Gums JG (2016) The emergence and evolution of antimicrobial resistance: impact on a global scale. Bioorg Med Chem 24:6440–6445. https://doi.org/10.1016/j.bmc.2016.04.027
Ivanov M, Kostić M, Stojković D, Soković M (2022) Rosmarinic acid—modes of antimicrobial and antibiofilm activities of a common plant polyphenol. S Afr J Bot 146:521–527. https://doi.org/10.1016/j.sajb.2021.11.050
Jangpromma N, Konkchaiyaphum M, Punpad A et al (2022) Rational design of RN15m4 cathelin domain-based peptides from siamese crocodile cathelicidin improves antimicrobial activity. Appl Biochem Biotechnol. https://doi.org/10.1007/s12010-022-04210-1
Jelinkova P, Mazumdar A, Sur VP et al (2019) Nanoparticle-drug conjugates treating bacterial infections. J Control Release 307:166–185. https://doi.org/10.1016/j.jconrel.2019.06.013
Jia Y, Lu H, Zhu L (2022) Molecular mechanism of antibiotic resistance induced by mono- and twin-chained quaternary ammonium compounds. Sci Total Environ 832:155090. https://doi.org/10.1016/j.scitotenv.2022.155090
Kalimuthu K, Srinivasan NR, Govindarajan G (2023) Antibiotic-peptide conjugation against multi-drug resistant pathogens: a comprehensive review for therapeutics and drug delivery strategies. Int J Pept Res Ther 29:91. https://doi.org/10.1007/s10989-023-10561-y
Kang X, Yan J, Huang F, Yang L (2019) On the mechanism of antibiotic resistance and fecal microbiota transplantation. Math Biosci Eng 16:7057–7084. https://doi.org/10.3934/mbe.2019354
Karakonstantis S, Rousaki M, Kritsotakis EI (2022) Cefiderocol: systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance. Antibiotics 11:723. https://doi.org/10.3390/antibiotics11060723
Kardos N (2017) Overuse of antibiotics and antibiotic resistance in medical applications featuring carbapenemase resistant enterobacteriaceae (CRE)
Kernou O-N, Azzouz Z, Madani K, Rijo P (2023) Application of rosmarinic acid with its derivatives in the treatment of microbial pathogens. Molecules 28:4243. https://doi.org/10.3390/molecules28104243
Khalid K, Poh CL (2023) The promising potential of reverse vaccinology-based next-generation vaccine development over conventional vaccines against antibiotic-resistant bacteria. Vaccines (basel) 11:1264. https://doi.org/10.3390/vaccines11071264
Kimura K (2019) Liposidomycin, the first reported nucleoside antibiotic inhibitor of peptidoglycan biosynthesis translocase I: the discovery of liposidomycin and related compounds with a perspective on their application to new antibiotics. J Antibiot (tokyo) 72:877–889. https://doi.org/10.1038/s41429-019-0241-5
Klahn P, Brönstrup M (2017) Bifunctional antimicrobial conjugates and hybrid antimicrobials. Nat Prod Rep 34:832–885. https://doi.org/10.1039/C7NP00006E
Klemm EJ, Wong VK, Dougan G (2018) Emergence of dominant multidrug-resistant bacterial clades: lessons from history and whole-genome sequencing. Proc Natl Acad Sci USA 115:12872–12877. https://doi.org/10.1073/pnas.1717162115
Koo HB, Seo J (2019) Antimicrobial peptides under clinical investigation. Pept Sci. https://doi.org/10.1002/pep2.24122
Kusaka S, Yamamoto K, Shinohara M, Minato Y, Ichikawa S (2022) Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5′-O-aminoribosyluridine as MraY inhibitors. Bioorg Med Chem 65:116744. https://doi.org/10.1016/j.bmc.2022.116744
Lee Ventola C (2015) The antibiotic resistance crisis. P&T 11:181–224. https://doi.org/10.1016/B978-1-4831-9711-1.50022-3
León-Buitimea A, Garza-Cárdenas CR, Garza-Cervantes JA et al (2020) The demand for new antibiotics: antimicrobial peptides, nanoparticles, and combinatorial therapies as future strategies in antibacterial agent design. Front Microbiol. https://doi.org/10.3389/fmicb.2020.01669
Li C, Alam K, Zhao Y et al (2021) Mining and biosynthesis of bioactive lanthipeptides from microorganisms. Front Bioeng Biotechnol. https://doi.org/10.3389/fbioe.2021.692466
Li Y, Ouyang Y, Wu H et al (2022) The discovery of 1, 3-diamino-7H-pyrrol[3, 2-f]quinazoline compounds as potent antimicrobial antifolates. Eur J Med Chem 228:113979. https://doi.org/10.1016/j.ejmech.2021.113979
Ling LL, Schneider T, Peoples AJ et al (2015) A new antibiotic kills pathogens without detectable resistance. Nature 517:455–459. https://doi.org/10.1038/nature14098
Martin JK, Sheehan JP, Bratton BP et al (2020) A dual-mechanism antibiotic kills gram-negative bacteria and avoids drug resistance. Cell 181:1518-1532.e14. https://doi.org/10.1016/j.cell.2020.05.005
Morehead MS, Scarbrough C (2018) Emergence of global antibiotic resistance. Primary Care Clin off Pract 45:467–484. https://doi.org/10.1016/j.pop.2018.05.006
Mullard A (2021) 2020 FDA drug approvals. Nat Rev Drug Discov 20:85–90
Mullard A (2022) 2021 FDA approvals. Nat Rev Drug Discov 21:83–88
Munita JM, Arias CA (2016) Mechanisms of antibiotic resistance. Virulence mechanisms of bacterial pathogens. ASM Press, Washington, DC, pp 481–511
Nakaya T, Yabe M, Mashalidis EH et al (2022) Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY. Nat Commun 13:7575. https://doi.org/10.1038/s41467-022-35227-z
National Health Commission of China (2023) National Antibiotic Resistance Monitoring Report 2021
New drug approvals (2022) New drug approvals. https://www.drugs.com/newdrugs.html. Accessed 14 Aug 2022
Okamoto K, Ishikawa A, Okawa R et al (2022) Design, synthesis and biological evaluation of simplified analogues of MraY inhibitory natural product with rigid scaffold. Bioorg Med Chem 55:116556. https://doi.org/10.1016/j.bmc.2021.116556
Pokhrel R, Bhattarai N, Baral P et al (2022) Lipid II binding and transmembrane properties of various antimicrobial lanthipeptides. J Chem Theory Comput 18:516–525. https://doi.org/10.1021/acs.jctc.1c00666
Porras-Alcalá C, Moya-Utrera F, García-Castro M et al (2022) The development of the bengamides as new antibiotics against drug-resistant bacteria. Mar Drugs 20:373. https://doi.org/10.3390/md20060373
Qi Y, Tang X, Wei N, Pang C, Du S, Wang K (2022) Discovery, synthesis, and optimization of teixobactin, a novel antibiotic without detectable bacterial resistance. J Pept Sci. https://doi.org/10.1002/psc.3428
Romanovska A, Keil J, Tophoven J et al (2021) Conjugates of ciprofloxacin and amphiphilic block copoly(2-alkyl-2-oxazolines)s overcome efflux pumps and are active against CIP-resistant bacteria. Mol Pharm 18:3532–3543. https://doi.org/10.1021/acs.molpharmaceut.1c00430
Rončević T, Gerdol M, Mardirossian M et al (2022) Anisaxins, helical antimicrobial peptides from marine parasites, kill resistant bacteria by lipid extraction and membrane disruption. Acta Biomater 146:131–144. https://doi.org/10.1016/j.actbio.2022.04.025
Sanchari Sinha Dutta (2022) The history of antibiotics. News Medical
Shukla R, Medeiros-Silva J, Parmar A et al (2020) Mode of action of teixobactins in cellular membranes. Nat Commun 11:2848. https://doi.org/10.1038/s41467-020-16600-2
Shukla R, Lavore F, Maity S et al (2022) Teixobactin kills bacteria by a two-pronged attack on the cell envelope. Nature 608:390–396. https://doi.org/10.1038/s41586-022-05019-y
Skłodowski K, Chmielewska-Deptuła SJ, Piktel E et al (2023) Metallic nanosystems in the development of antimicrobial strategies with high antimicrobial activity and high biocompatibility. Int J Mol Sci 24:2104. https://doi.org/10.3390/ijms24032104
Stachurski O, Neubauer D, Walewska A et al (2022) Understanding the role of self-assembly and interaction with biological membranes of short cationic lipopeptides in the effective design of new antibiotics. Antibiotics 11:1491. https://doi.org/10.3390/antibiotics11111491
Tagliabue A, Rappuoli R (2018) Changing priorities in vaccinology: antibiotic resistance moving to the top. Front Immunol. https://doi.org/10.3389/fimmu.2018.01068
Talbot GH, Jezek A, Murray BE et al (2019) The infectious diseases society of America’s 10 × ’20 initiative (10 new systemic antibacterial agents US food and drug administration approved by 2020): Is 20 × ’20 a possibility? Clin Infect Dis 69:1–11. https://doi.org/10.1093/cid/ciz089
Terreni M, Taccani M, Pregnolato M (2021) New antibiotics for multidrug-resistant bacterial strains: latest research developments and future perspectives. Molecules 26:2671. https://doi.org/10.3390/molecules26092671
Tian J, Chen S, Liu F, Zhu Q, Shen J, Lin W, Zhu K (2022) Equisetin targets intracellular Staphylococcus aureus through a host acting strategy. Mar Drugs 20:656. https://doi.org/10.3390/md20110656
Udaondo Z, Matilla MA (2020) Mining for novel antibiotics in the age of antimicrobial resistance. Microb Biotechnol 13:1702–1704. https://doi.org/10.1111/1751-7915.13662
Uddin TM, Chakraborty AJ, Khusro A et al (2021) Antibiotic resistance in microbes: history, mechanisms, therapeutic strategies and future prospects. J Infect Public Health 14:1750–1766. https://doi.org/10.1016/j.jiph.2021.10.020
Waack U, Nicholson TL (2018) Subinhibitory concentrations of amoxicillin, lincomycin, and oxytetracycline commonly used to treat swine increase Streptococcus suis biofilm formation. Front Microbiol 9:1–10. https://doi.org/10.3389/fmicb.2018.02707
Wang Z, Koirala B, Hernandez Y, Zimmerman M, Brady SF (2022) Bioinformatic prospecting and synthesis of a bifunctional lipopeptide antibiotic that evades resistance. Science (1979) 376:991–996. https://doi.org/10.1126/science.abn4213
Wettstadt S (2020) Protect thy host: Pf4 phages shield Pseudomonas aeruginosa from antibiotics. Environ Microbiol 22:2461–2462. https://doi.org/10.1111/1462-2920.15046
White K, Nicoletti G, Cornell H (2021) Antibacterial profile of a microbicidal agent targeting tyrosine phosphatases and redox thiols. Novel Drug Targets Antibiot 10:1310. https://doi.org/10.3390/antibiotics10111310
WHO Library (2023) WHO Library of AMR national action plans. https://www.who.int/teams/surveillance-prevention-control-AMR/national-action-plan-monitoring-evaluation/library-of-national-action-plans. Accessed 22 Sep 2023
WHO-Policy (2011) WHO-Policy-Package-to-Combat-Antimicrobial-Resistance
Willson J (2022) Novel antibiotics from bacterial blueprints. Nat Rev Drug Discov 21:492–492. https://doi.org/10.1038/d41573-022-00102-5
Windham S, Kollef MH (2022) How to use new antibiotics in the therapy of serious multidrug resistant Gram-negative infections? Curr Opin Infect Dis 35:561–567. https://doi.org/10.1097/QCO.0000000000000858
World Health Organization (2015) Global action plan on antimicrobial resistance
World Health Organization (2020) Antibiotic resistance. https://www.who.int/news-room/fact-sheets/detail/antibiotic-resistance. Accessed 26 Oct 2022
World Health Organization (2022) Lack of innovation set to undermine antibiotic performance and health gains. https://www.who.int/news/item/22-06-2022-22-06-2022-lack-of-innovation-set-to-undermine-antibiotic-performance-and-health-gains. Accessed 22 Oct 2022
World Health Organization (2023) Health and economic impacts of antimicrobial resistance in the Western Pacific Region, 2020–2030
World Health Organization Regional Office for Europe (2023) Antimicrobial resistance surveillance in Europe (2023)
Wray R, Wang J, Blount P, Iscla I (2022) Activation of a bacterial mechanosensitive channel, MscL, underlies the membrane permeabilization of dual-targeting antibacterial compounds. Antibiotics 11:970. https://doi.org/10.3390/antibiotics11070970
Wu H, Chen H, Zhang J et al (2022) The anti-multidrug-resistant Acinetobacter baumannii study on 1,3-diamino-7H-pyrrolo[3,2-f]quinazoline compounds. Molecules 27:8609. https://doi.org/10.3390/molecules27238609
Yamauchi R, Kawano K, Yamaoka Y, Taniguchi A, Yano Y, Takasu K, Matsuzaki K (2022) Development of antimicrobial peptide-antibiotic conjugates to improve the outer membrane permeability of antibiotics against gram-negative bacteria. ACS Infect Dis 8:2339–2347. https://doi.org/10.1021/acsinfecdis.2c00406
Ye J, Chen X (2022) Current promising strategies against antibiotic-resistant bacterial infections. Antibiotics 12:67. https://doi.org/10.3390/antibiotics12010067
Yu L, Shang Z, Jin Q, Chan SY, Hong W, Li N, Li P (2023) Antibody-antimicrobial conjugates for combating antibiotic resistance. Adv Healthc Mater 12:2202207. https://doi.org/10.1002/adhm.202202207
Zadeh SM, Chen M-H, Wang Z-C et al (2022) β-Hydroxylation of α-amino-β-hydroxylbutanoyl-glycyluridine catalyzed by a nonheme hydroxylase ensures the maturation of caprazamycin. Commun Chem 5:87. https://doi.org/10.1038/s42004-022-00703-6
Zhang Q, Chen S, Liu X, Lin W, Zhu K (2021) Equisetin restores colistin sensitivity against multi-drug resistant gram-negative bacteria. Antibiotics 10:1263. https://doi.org/10.3390/antibiotics10101263
Zhang J, Cui X, Zhang M, Bai B, Yang Y, Fan S (2022) The antibacterial mechanism of perilla rosmarinic acid. Biotechnol Appl Biochem 69:1757–1764. https://doi.org/10.1002/bab.2248
Zhao X, Xu Y, Viel JH, Kuipers OP (2021) Semisynthetic macrocyclic lipo-lanthipeptides display antimicrobial activity against bacterial pathogens. ACS Synth Biol 10:1980–1991. https://doi.org/10.1021/acssynbio.1c00161
Zhou M, Qian Y, Xie J, Zhang W et al (2020) Poly(2-Oxazoline)-based functional peptide mimics: eradicating MRSA infections and persisters while alleviating antimicrobial resistance. Angew Chem Int Ed 59:6412–6419. https://doi.org/10.1002/anie.202000505
Funding
This research was sponsored by the National Natural Science Foundation of China (Grant No. 81873134), the Project of Philosophy and Social Science Research in Colleges and Universities in Jiangsu Province (Grant No. 2021SJA1939).
Author information
Authors and Affiliations
Contributions
Conceptualization, SK; writing—original draft preparation, LC; writing—review and editing, SK; funding acquisition, HW. All authors have read and agreed to the published version of the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of the data; in the writing of the manuscript; or in the decision to publish the results.
Informed consent statement
Not applicable.
Institutional review board statement
Not applicable.
Additional information
Communicated by Yusuf Akhter.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Chen, L., Kumar, S. & Wu, H. A review of current antibiotic resistance and promising antibiotics with novel modes of action to combat antibiotic resistance. Arch Microbiol 205, 356 (2023). https://doi.org/10.1007/s00203-023-03699-2
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00203-023-03699-2